Knowthestock.com
BIOL - Biolase Inc

Sell

Weak GrowthEarnings/Profit is Negative

20%

based on last 5 year data.
Income Statement is WEAK
Revenue Growth is 94.59%
Operating Income is Negative
Net Income is Negative but improving
Earnings Per Share (EPS) is Negative but improving
Net Margin is -36.94%
Balance Sheet is STRONG
Current Asset to Current Liability Ratio is 3.91
Debt Ratio is 0.48
Current Debt to Net Income Ratio not available
Total Debt to Total Assets Ratio is 0.25
Cash Flow is WEAK
Cash from Operations is Negative but improving
Capital Expenditure not available
Net Increase in Cash is Positive
Long Term Score Trend is POSITIVE
Investment Risk is High
based on last 4 quarter data.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.
Biolase Inc (BIOL) - www.biolase.com
BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 271 patented and 40 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times. BIOLASE's innovative products provide cutting-edge technology at competitive prices to deliver superior results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. BIOLASE has sold over 41,200 laser systems to date in over 80 countries around the world. Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer applications.
Exchange - NASDAQ
Industry - Dental Equipment and Supplies Manufacturing
Sector - Manufacturing
CEO - Todd Norbe
Employees - 135
    Close


Disclaimer - Investment in securities involves substantial risk and could result in significant loss. It is not suitable for every investor. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. We may own some of the securities mentioned in this website.
Know the Stock © 2021 and future.